Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

TD Bank, Boeing And Medicare: Compliance Headlines In 2024 No Photo Available

Sarah Jarvis

Corporate compliance lessons were never far from the headlines in 2024, as regulatory challenges and headaches facing industries rangi... (more story)

Top Government Contracts Of 2024: Year In Review No Photo Available

Daniel Wilson

This year, the U.S. General Services Administration made dozens of awards for two massive, uncapped governmentwide deals, while the U.... (more story)

The Most Significant Trade Secrets Cases Of 2024 No Photo Available

Ivan Moreno

Insulet Corp. became the latest company to notch a colossal trade secrets award, and a new presidential administration has attorneys w... (more story)